Evidence map›Paper›PMID 39805972›Full record

ArticleScientific reports2025

High throughput method for simultaneous screening of membrane permeability and toxicity for discovery of new cryoprotective agents.

Nima Ahmadkhani, James D Benson, Ali Eroglu, Adam Z Higgins

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Molecular Mechanisms of Basil (Molecules (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Thermodynamic Principles of Emerging Cryopreservation Technologies.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. A size-dependent ideal solution model for liquid-solid phase equilibria prediction in aqueous organic solutions.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Nima AhmadkhaniSchool of Chemical, Biological, and Environmental Engineering, Oregon State University, Corvallis, USA.
James D BensonDepartment of Biology, University of Saskatchewan, Saskatoon, Canada.
Ali ErogluDepartment of Neuroscience and Regenerative Medicine, Medical College of Georgia - Augusta University, Augusta, USA.
Adam Z HigginsSchool of Chemical, Biological, and Environmental Engineering, Oregon State University, Corvallis, USA. Adam.Higgins@oregonstate.edu.

Funding

Viable Banking of Human TissuesR01EB027203 · NIBIB · AUGUSTA UNIVERSITY · PI EROGLU, ALI · 2018 to 2021
$1.5M
Cryonics Institute DonationNIBIB NIH HHS R01 EB027203NIH HHS R01 EB027203
6 · The paper itself

Abstract

Cryoprotective agent (CPA) toxicity is the most limiting factor impeding cryopreservation of critically needed tissues and organs for transplantation and medical research. This limitation is in part due to the challenge of rapidly screening compounds to identify candidate molecules that are highly membrane permeable and non-toxic at high concentrations. Such a combination would facilitate rapid CPA permeation throughout the sample, enabling ice-free cryopreservation with minimal toxicity. This study presents a new method for rapidly assessing the cell membrane permeability and toxicity of candidate CPAs. The new method enables ~ 100 times faster permeability measurement than previous methods, while also allowing assessment of CPA toxicity using the same 96-well plate. We tested five commonly used CPAs and 22 less common ones at both 4 °C and room temperature, with 23 of them passing the screening process based on their favorable toxicity and permeability properties. Considering its advantages such as high throughput measurement of membrane permeability along with simultaneous toxicity assessment, the presented method holds promise as an effective initial screening tool to identify new CPAs for cryopreservation.

Indexed as

Cell Membrane PermeabilityCryoprotective AgentsHigh-Throughput Screening AssaysAnimalsCryopreservationHumansCryoprotective AgentsCell membrane permeabilityCPACryopreservationCryoprotectantFreezingVitrification

Identifiers

PMID39805972
PMCPMC11731021

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.